Regulation of hepatitis C virus polyprotein processing by signal peptidase involves structural determinants at the p7 sequence junctions. The Journal of biological chemistry, 279, 41384-41392

Institut de Biologie de Lille, Lille, Nord-Pas-de-Calais, France
Journal of Biological Chemistry (Impact Factor: 4.57). 11/2004; 279(40):41384-92. DOI: 10.1074/jbc.M406315200
Source: PubMed

ABSTRACT The hepatitis C virus genome encodes a polyprotein precursor that is co- and post-translationally processed by cellular and viral proteases to yield 10 mature protein products (C, E1, E2, p7, NS2, NS3, NS4A, NS4B, NS5A, and NS5B). Although most cleavages in hepatitis C virus polyprotein precursor proceed to completion during or immediately after translation, the cleavages mediated by a host cell signal peptidase are partial at the E2/p7 and p7/NS2 sites, leading to the production of an E2p7NS2 precursor. The sequences located immediately N-terminally of E2/p7 and p7/NS2 cleavage sites can function as signal peptides. When fused to a reporter protein, the signal peptides of p7 and NS2 were efficiently cleaved. However, when full-length p7 was fused to the reporter protein, partial cleavage was observed, indicating that a sequence located N-terminally of the signal peptide reduces the efficiency of p7/NS2 cleavage. Sequence analyses and mutagenesis studies have also identified structural determinants responsible for the partial cleavage at both the E2/p7 and p7/NS2 sites. Finally, the short distance between the cleavage site of E2/p7 or p7/NS2 and the predicted transmembrane alpha-helix within the P' region might impose additional structural constraints to the cleavage sites. The insertion of a linker polypeptide sequence between P-3' and P-4' of the cleavage site released these constraints and led to improved cleavage efficiency. Such constraints in the processing of a polyprotein precursor are likely essential for hepatitis C virus to post-translationally regulate the kinetics and/or the level of expression of p7 as well as NS2 and E2 mature proteins.

Download full-text


Available from: Laurence Cocquerel, Apr 07, 2014
1 Follower
  • Source
    • "Published online in Wiley InterScience ( mediated by a cellular signal peptidase [Lin et al., 1994; Mizushima et al., 1994; Carrere-Kremer et al., 2004]. However, it is not known whether p7 is a structural or a non-structural protein and whether or not it is associated with HCV particles. "
    [Show abstract] [Hide abstract]
    ABSTRACT: A clinical study was carried out to compare the response rate of two groups of non-responder (NR) hepatitis C virus (HCV) genotype 1 chronically infected patients treated with interferon and ribavirin, with or without amantadine. The viral load decreased more markedly in the group treated by tritherapy including amantadine, but the response rate at the end of treatment was not significantly different between bitherapy and tritherapy. As amantadine could have an antiviral effect on the ion channel activity of the p7 HCV protein, the p7 quasispecies was characterized by cloning and sequencing. Sequence data were analyzed to determine the pattern and significance of p7 genetic heterogeneity and a possible relationship with therapy. Subtype differences were confirmed between p7 HCV genotypes 1a and 1b, and quasispecies analysis showed a reduction of genetic diversity in subtype 1a, but not 1b, during tritherapy. However, the absence of changes at numerous positions, as well as the conservative changes at other positions, indicated the high conservation of the p7 structure. Residue His-17, proposed to interact with amantadine, was fully conserved in both subtypes 1a and 1b, independently of amantadine administration. In conclusion, although the analysis of the p7 sequences revealed a selective pressure during therapy, no specific residues appeared to be linked to the effect of amantadine on viral decline. These results suggest that the potential antiviral effect of amantadine might be non-specific and related to a reduction in endosomal acidification and therefore reduced viral entry of HCV via its pH-dependent pathway.
    Journal of Medical Virology 02/2007; 79(2):144-54. DOI:10.1002/jmv.20772 · 2.22 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The Hepatitis C virus (HCV) genome encodes a polyprotein that is processed co-and post-translationally. Incomplete processing at the E2/p7 junction generates the E2p7 product. Using a recombinant system, we analysed the processing, localization and topology of E2p7. By immunoprecipitation of proteins expressed by metabolically labelled cells, we confirm that E2p7 is a precursor of E2. E2p7 forms a native-like heterodimer with E1, and it is localized entirely to the endoplasmic reticulum, in contrast to fully processed E2 and p7 that leak to the plasma membrane. No change in the topology of p7 was observed upon processing of E2p7, indicating that incomplete cleavage at the E2/p7 site is not regulated by changes in p7 membrane topology.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The RNA genome of hepatitis A virus (HAV) shares common characteristics of the picornavirus family. However, the nucleotide or amino acid sequences are distantly related with other members of the family. Like other picornaviruses, HAV proteins are cleaved from a large polyprotein (PO), but the processing and some products are quite different. The 3C protein is the sole processing enzyme, and the primary cleavage takes place at the 2A/2B site. Several VP1-2A sites are proposed. In some strains, the intermediate VP1-2A polypeptides are assembled in the virion. The VP4 is very small and not detected in the mature virion. Some mutations in 2B, 2C and 3A proteins are identified to enhance viral replication or to induce cytopathogenic effects in the viruses adapted to cell cultures.
    Intervirology 02/1999; 42(2-3):63-8. DOI:10.1159/000024967 · 1.77 Impact Factor
Show more